SCHEMBL5801465

SCHEMBL5801465

CCN(NCc1ccc(O)c(OC)c1)C(=O)c1cccc(NC(=O)CCOC(=O)N(c2ccccc2-c2ccccc2)N2CC[CH]CC2)c1

nearest known ligand 0.34

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
TRPV1 Q8NER1 2/20 0.34
POLB P06746 2/20 0.33
LMNA P02545 1/20 0.33
SENP1 Q9P0U3 1/20 0.32
USP2 O75604 1/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 2/20 0.32
GAA P10253 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
ADRB2 P07550 1/20 0.32
CHRM3 P20309 1/20 0.32
RAB9A P51151 1/20 0.32
ALDH1A1 P00352 1/20 0.32
HTR1A P08908 1/20 0.32
HTR7 P34969 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6021946 0.81 TRPV1 (0.47) MEN1KMT2ATRPV1POLBHPGD
SCHEMBL5803533 0.80 ERCC1 (0.30)
SCHEMBL3175566 0.76 CHRM3 (0.54) ADRB2CHRM3
SCHEMBL5802413 0.76 CD274 (0.37) SMN1; SMN2ADRB2CHRM3RAB9A
SCHEMBL6022345 0.74 CYP1A2 (0.37) TRPV1HTR1A
SCHEMBL5800718 0.74 ATR (0.36) MEN1KMT2APOLBMAPTHPGD
SCHEMBL5275258 0.73 ATR (0.34) MEN1KMT2APOLBMAPTHPGD
SCHEMBL5273313 0.73 ATR (0.36) MEN1KMT2ATRPV1POLBMAPT
SCHEMBL5804676 0.71 ALDH1A1 (0.35) MEN1KMT2ALMNAMAPTGAA
SCHEMBL6021981 0.71 RECQL (0.34) MEN1KMT2ALMNAMAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006098997-A1 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS THERAVANCE, INC. (US) 2006-09-21 WO disclosed
WO-2006099091-A1 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS THERAVANCE, INC. (US) 2006-09-21 WO disclosed